Insider Selling: Ainos (NASDAQ:AIMD) Major Shareholder Sells $96,760.00 in Stock

Ainos, Inc. (NASDAQ:AIMD) major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $2.36, for a total transaction of $96,760.00. Following the sale, the insider owned 948,925 shares of the company’s stock, valued at $2,239,463. This trade represents a 4.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Ainos Stock Performance

NASDAQ AIMD opened at $2.38 on Friday. Ainos, Inc. has a 52-week low of $1.26 and a 52-week high of $4.50. The company has a 50-day simple moving average of $1.71 and a 200 day simple moving average of $1.83. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.50 and a current ratio of 0.55. The company has a market capitalization of $20.29 million, a PE ratio of -0.82 and a beta of 2.29.

Ainos (NASDAQ:AIMD) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Ainos currently has an average rating of “Sell”.

Hedge Funds Weigh In On Ainos

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Mariner LLC bought a new position in Ainos during the fourth quarter worth about $37,000. Two Sigma Investments LP bought a new position in Ainos during the third quarter worth about $80,000. DRW Securities LLC boosted its position in Ainos by 272.6% during the fourth quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after purchasing an additional 48,439 shares during the period. Finally, Renaissance Technologies LLC boosted its position in Ainos by 13.1% during the fourth quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after purchasing an additional 7,700 shares during the period.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.